| The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ... Drugs 81, 1703-1729, 2021 | 234 | 2021 |
| Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap F Daneshnia, JN de Almeida Júnior, M Ilkit, L Lombardi, AM Perry, M Gao, ... The Lancet Microbe, 2023 | 49 | 2023 |
| Prevalence of COVID-19-associated pulmonary aspergillosis: critical review and conclusions M Egger, L Bussini, M Hoenigl, M Bartoletti Journal of Fungi 8 (4), 390, 2022 | 43 | 2022 |
| WHO Guidelines Development Group. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective B Allegranzi, B Zayed, P Bischoff, NZ Kubilay, S De Jonge, F De Vries, ... Lancet Infect Dis 16 (12), e288-e303, 2016 | 39 | 2016 |
| Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study M Hoenigl, J Salmanton-García, M Egger, JP Gangneux, T Bicanic, ... The Lancet Infectious Diseases 23 (6), 751-761, 2023 | 38 | 2023 |
| Metabolic dysfunction-associated fatty liver disease (MAFLD)—rather a bystander than a driver of mortality G Semmler, S Wernly, S Bachmayer, I Leitner, B Wernly, M Egger, ... The Journal of Clinical Endocrinology & Metabolism 106 (9), 2670-2677, 2021 | 37 | 2021 |
| Let's talk about sex characteristics—as a risk factor for invasive fungal diseases M Egger, M Hoenigl, GR Thompson Iii, A Carvalho, JD Jenks Mycoses 65 (6), 599-612, 2022 | 36 | 2022 |
| Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a multicenter study B Autier, J Prattes, PL White, M Valerio, M Machado, J Price, M Egger, ... Journal of clinical microbiology 60 (1), e01689-21, 2022 | 31 | 2022 |
| Blood Aspergillus PCR: the good, the bad, and the ugly M Egger, JD Jenks, M Hoenigl, J Prattes Journal of Fungi 6 (1), 18, 2020 | 31 | 2020 |
| Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action M Hoenigl, R Sprute, A Arastehfar, JR Perfect, C Lass-Flörl, R Bellmann, ... Expert opinion on investigational drugs 31 (8), 795-812, 2022 | 27 | 2022 |
| Metagenomic next-generation sequencing of plasma for diagnosis of COVID-19-associated pulmonary aspergillosis M Hoenigl, M Egger, J Price, R Krause, J Prattes, PL White Journal of Clinical Microbiology 61 (3), e01859-22, 2023 | 23 | 2023 |
| Race and ethnicity: Risk factors for fungal infections? JD Jenks, CI Aneke, MM Al-Obaidi, M Egger, L Garcia, T Gaines, ... PLoS pathogens 19 (1), e1011025, 2023 | 19 | 2023 |
| Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management GR Thompson III, JD Jenks, JW Baddley, JS Lewis, M Egger, IS Schwartz, ... Clinical microbiology reviews 36 (3), e00019-23, 2023 | 18 | 2023 |
| Performance of the Euroimmun Aspergillus antigen ELISA for the diagnosis of invasive pulmonary aspergillosis in bronchoalveolar lavage fluid M Egger, S Penziner, K Dichtl, M Gornicec, L Kriegl, R Krause, E Khong, ... Journal of clinical microbiology 60 (4), e00215-22, 2022 | 17 | 2022 |
| Treatment of invasive aspergillosis: how it’s going, where it’s heading J Boyer, S Feys, I Zsifkovits, M Hoenigl, M Egger Mycopathologia 188 (5), 667-681, 2023 | 16 | 2023 |
| Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study M Hoenigl, M Egger, J Boyer, E Schulz, J Prattes, JD Jenks Mycoses 64 (10), 1197-1202, 2021 | 16 | 2021 |
| Non-invasive three-dimensional electrical activation mapping to predict cardiac resynchronization therapy response: site of latest left ventricular activation relative to … L Parreira, A Tsyganov, E Artyukhina, K Vernooy, C Tondo, P Adragao, ... Europace 25 (4), 1458-1466, 2023 | 13 | 2023 |
| Siderophores: a potential role as a diagnostic for invasive fungal disease L Kriegl, V Havlicek, K Dichtl, M Egger, M Hoenigl Current opinion in infectious diseases 35 (6), 485-492, 2022 | 13 | 2022 |
| Antifungal stewardship in solid organ transplantation L Kriegl, J Boyer, M Egger, M Hoenigl Transplant Infectious Disease 24 (5), e13855, 2022 | 12 | 2022 |
| Treatment of Fusarium infection of the central nervous system: a review of past cases to guide therapy for the ongoing 2023 outbreak in the United States and Mexico M Hoenigl, JD Jenks, M Egger, M Nucci, GR Thompson III Mycopathologia 188 (6), 973-981, 2023 | 11 | 2023 |
